Sensei Biotherapeutics
SNSE
NASDAQ
IPO2021
about SNSE
Sensei Biotherapeutics is a biotechnology company focused on developing innovative cancer immunotherapies that combine immune cell engineering with proprietary technologies to create targeted and potent treatments designed to empower the immune system to fight cancer effectively.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $8.37 | $10.98 | $8.37 | $11.16M | 201.40K |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$3.62 | n/a | n/a | 0% | 0% | 0% |